Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Samuel N. Outteridge"'
Autor:
Rachael E. Faulkner, Samuel N. Outteridge, David H. Dockrell, Robert F. Storey, Rosemary Ecob, Laura West, Mark R Thomas, Fladia Phoenix, Ramzi Ajjan, Heather M Judge, Haroon Khan, Ian Sabroe, Gurpreet K. Sangha
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 35:2562-2570
Objective— Clinical studies suggest that platelet P2Y 12 inhibitors reduce mortality from sepsis, although the underlying mechanisms have not been clearly defined in vivo. We hypothesized that P2Y 12 inhibitors may improve survival from sepsis by s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c583ba91d6aa9b4a9aed286856e8681d
https://doi.org/10.1161/atvbaha.115.306528
https://doi.org/10.1161/atvbaha.115.306528
Autor:
Samuel N. Outteridge, David H. Dockrell, Robert F. Storey, Ramzi A. Ajjan, Ian Sabroe, Mark S. Thomas, Fladia Phoenix
Publikováno v:
Heart. 101:A112.1-A112
Introduction In the PLATO study, the novel platelet P2Y 12 inhibitor ticagrelor was unexpectedly associated with fewer deaths following pulmonary infections and sepsis than clopidogrel. The risk of myocardial infarction or stroke is greatly increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50a4db8b49215eb9e2d9ae2bb5b57107
https://doi.org/10.1136/heartjnl-2015-308066.203
https://doi.org/10.1136/heartjnl-2015-308066.203
Autor:
Samuel N. Outteridge, Ian Sabroe, Robert F. Storey, Fladia Phoenix, David H. Dockrell, Ramzi Ajjan, Mark R Thomas
Publikováno v:
Journal of the American College of Cardiology. 65:A12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2e3de8a1e6e0a380d1af99e2f519f3
https://doi.org/10.1016/s0735-1097(15)60012-2
https://doi.org/10.1016/s0735-1097(15)60012-2